v3.25.4
Schedule of Key Valuation Inputs (Details) (Parenthetical)
Dec. 31, 2025
$ / shares
Jun. 30, 2025
$ / shares
Dec. 31, 2024
$ / shares
Aug. 31, 2024
$ / shares
Series 1 Convertible Debt [Member]        
Short-Term Debt [Line Items]        
CD2 note 5.0      
Conversion price | (per share) $ 3.675 $ 10.50 $ 7.280 $ 10.50
Series 1 Convertible Debt [Member] | Measurement Input, Credit Spread [Member]        
Short-Term Debt [Line Items]        
CD2 note 7.23   4.72 [1],[2],[3]  
Series 2 Convertible Debt [Member]        
Short-Term Debt [Line Items]        
CD2 note 10.0      
Conversion price | (per share) $ 3.675 $ 10.15 $ 7.070  
Series 2 Convertible Debt [Member] | Measurement Input, Credit Spread [Member]        
Short-Term Debt [Line Items]        
CD2 note 9.32   5.03 [1],[2],[3]  
[1] CD1 carries an instrument-specific spread of 7.23%, CD2 carries an instrument-specific spread of 9.32%
[2] The CD1 carried a Discount for Lack of Marketability (“DLOM”) of 5.0% as of the issuance date. The CD2 carried a DLOM of 10.0% as of the issuance date.
[3] The conversion price of the CD1 is $3.675 and $7.280 CD2 is $3.675 and $7.070 as of December 31, 2025 and December 31, 2024 respectively.